Altos Labs, backed by $3 billion from Jeff Bezos and others, has snagged a small Peninsula company focused on one approach to stopping aging ...

Unicycive Therapeutics, Inc. (NASDAQ: UNCY) (“Unicycive” or the “Company”), a clinical stage biotechnology company developing ...

A link to the live and archived webcasts may be accessed on the Unicycive website under the Investors section: Events and ...

New Drug Application (NDA) for hyperphosphatemia in chronic kidney disease patients on dialysis under review by FDA with ...

Other noteworthy biotech startups developing drugs that aim ... years ago and is reportedly raising a $1 billion Series A; and Altos Labs, which launched with $3 billion in 2022 and is backed ...

Altos, led by industry stalwarts Hal Barron and Hans Bishop, brought Dorian Therapeutics into its fold this week, according ...

NewLimit, a biotechnology startup co-founded by Coinbase CEO Brian ... Amazon founder Jeff Bezos has thrown his weight behind another venture, Altos Labs, aiming to “reverse disease, injury, and the ...

An eight-member panel voted unanimously against wider use of Pfizer’s Talzenna in advanced prostate cancer. Elsewhere, U.K. regulators cleared Sarepta to restart an Elevidys study and Altos Labs ...

LOS ALTOS PARK HAS UNDERGONE JUST A STUNNING TRANSFORMATION. YOU DRIVE BY THAT THING, IT’S BEAUTIFUL. PEYTON SPELLACY IS LIVE WITH MORE ON THE WORK DONE. HEY, PEYTON. HEY. GOOD MORNING ...